ViiV Healthcare Renews its 2015 Collaboration with UNC-Chapel Hill to Discover a Cure for HIV

 ViiV Healthcare Renews its 2015 Collaboration with UNC-Chapel Hill to Discover a Cure for HIV

ViiV Healthcare Renews their 2015 Collaboration with UNC-Chapel Hill for Five Years

Shots:

  • ViiV Healthcare has renewed its research agreement with UNC-Chapel Hill to the tune of ~$20M over five years for solely focus on the discovery of therapies for HIV
  • The scientists from both the companies will work at the HIV Cure Center, which was created in 2015 at the start of the collaboration. The public-private collaboration will continue to jointly own Qura Therapeutics, a company managing the IP, commercialization, manufacturing and governance needs of the alliance
  • The partnership is the first-of-its-kind in HIV that brings academic and pharmaceutical research scientists together for developing a new approach to eradicate HIV

Click here ­to­ read full press release/ article | Ref: GSK | Image: Pinterest

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post